Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 4/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27921629 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 | |
| SCHEMBL826108 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 | |
| SCHEMBL825730 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 | |
| SCHEMBL826118 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 | |
| SCHEMBL3505565 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 | |
| SCHEMBL531066 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 | |
| SCHEMBL965875 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 | |
| SCHEMBL531229 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 | |
| SCHEMBL873446 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 | |
| SCHEMBL733379 | 0.97 | SMPD1 (0.50) | SMPD1OPRM1LMNAZDHHC7DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | claimed |
| US-11806448-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2023-11-07 | — | — | US | claimed |
| CN-110571471-B | Preparation method and application of solid electrolyte with post-wound rapid healing capacity | 河北师范大学 | 2022-12-09 | — | — | CN | claimed |
| CN-109694424-B | Catalyst component for ethylene polymerization, preparation method thereof and catalyst for ethylene polymerization | 中国石油化工股份有限公司 | 2021-08-03 | — | — | CN | claimed |
| CN-110571471-A | preparation method and application of solid electrolyte with post-wound rapid healing capacity | 河北师范大学 | 2019-12-13 | — | — | CN | claimed |
| CN-109694424-A | Catalytic component for vinyl polymerization and preparation method thereof and catalyst for vinyl polymerization | 中国石油化工股份有限公司 | 2019-04-30 | — | — | CN | claimed |
| CN-103221437-A | Polymer compound and resist protective film composition for liquid immersion exposure process containing same | DONGJIN SEMICOHEM CO LTD | 2013-07-24 | — | — | CN | claimed |
| EP-2094737-A1 | CATALYST COMPONENT FOR THE POLYMERIZATION OF OLEFINS | Basell Poliolefine Italia S.r.l. (IT) | 2009-09-02 | — | — | EP | claimed |
| WO-2008061662-A1 | CATALYST COMPONENT FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2008-05-29 | — | — | WO | claimed |
| US-5354911-A | From diacetals; catalyst composed of acid and amine | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-10-11 | — | — | US | claimed |
| EP-0363910-B1 | Method for controlling specific surface area of alumina | AGENCY IND SCIENCE TECHN (JP) | 1994-09-07 | — | — | EP | claimed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| EP-0012246-A1 | Aromatic and flavouring substances, their preparation by fermentation, their use and products containing them | L. Givaudan & Cie Société Anonyme (CH) | 1980-06-25 | — | — | EP | disclosed |
| EP-0010142-A1 | Sesquiterpenoid tetrahydrofuran derivatives (I) as isolated compounds or in the form of mixtures, process and starting materials (V) for their preparation, application of (I) as perfumes and/or flavors and perfume and/or flavor compositions with an amount of (I) | L. Givaudan & Cie Société Anonyme (CH) | 1980-04-30 | — | — | EP | disclosed |
| US-4180677-A | Novel prostaglandins | AMERICAN CYANAMID COMPANY (US) | 1979-12-25 | — | — | US | disclosed |
| EP-0003515-A1 | Megastigman-4,7-oxides(I) and 7-oxabicyclo(3,3,0)-octanes (II), process for the preparation of (I) and (II), use of (I) and (II) as fragrances and/or flavours, and fragrance and/or flavour compositions containing (I) or (II) | L. Givaudan & Cie Société Anonyme (CH) | 1979-08-22 | — | — | EP | disclosed |
| EP-0000719-A2 | 1,4-Epoxy-trimethyl-butenylidene-cyclohexanes (I), process for their preparation, use of (I) as fragrance and/or flavouring substance, fragrance and/or flavour compositions containing the cyclohexanes | L. Givaudan & Cie Société Anonyme (CH) | 1979-02-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | TAS2R42, TAS2R4, TAS2R41 | SMPD1 2783/4885OPRM1 269/4885LMNA 1935/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | SMPD1 1113/4885OPRM1 964/4885LMNA 399/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | SMPD1 3008/4885OPRM1 92/4885LMNA 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.